Action of aprotinin in myocardial ischemia - An investigation using a plasma-free model

Thoracic and Cardiovascular Surgeon

Volumn 47, Issue 2, 1999, Pages 88-93

  Hoffmeister, Hans Martin ^a,b   Fischer, M ^a   Kazmaier, S ^a   Heller, W ^a   Seipel, L ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Aprotinin; Myocardial ischemia; Troponin T

Indexed keywords

APROTININ; BRADYKININ; KALLIKREIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FIBRINOLYSIS; HEART INJURY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; MALE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEINASE INHIBITION; RAT; TISSUE SPECIFICITY;

EID: 0032953745     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1013117     Document Type: Article

References (29)

1. Force T, Hibbert P, Weeks GW, et al. Perioperative myocardial infarction after coronary artery bypass surgery: clinical significance and approach to risk stratification. Circulation. 1990; 82 : 903-12.
2. Katus HA, Loser S, Hallermayer K, et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem. 1992;38:386-93.
3. Mair J, Wieser Ch, Seibt I, et al. Troponin T to diagnose myocardial infarction in bypass surgery. Lancet. 1991;337: 334-5.
4. Katus HA, Schoeppenthau M, Tanzeem A, et al. Non-invasive assessment of perioperative myocardial cell damage by circulating cardiac troponin T. Br Heart J. 1991;5 : 259-64.
5. Alajmo F, Calamai G, Perna AM, et al. High-dose aprotinin: hemostatic effects in open heart operations. Ann Thorac Surg. 1989;48:536-9.
6. Bidstrup BP, Royston D, Sapsford RN, Taylor KN. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg. 1989;97: 364-72.
7. Dietrich W, Barankay A, Dilthey G, et al. Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application: clinical experience with 152 patients. Thorac Cardiovasc Surg. 1989;37 : 92-8.
8. Dietrich W, Spannagl M, Jochum A, et al. Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anaesthesiology. 1990;73:1119-29.
9. Dietrich W, Hähnel C, Richter JA. Routine application of high-dose aprotinin in open heart surgery: a study in 1784 patients. Anaesthesiology. 1990;73 (A1) : 46.
10. Fraedrich G, Weber C, Bernard C, Hettwer A, Schlosser V. Reduction of blood transfusion requirement in open heart surgery by administration of high dose aprotinin: preliminary results. Thorac Cardiovasc Surg. 1989;37: 89-91.
11. Fuhrer G, Gallimore MJ, Heller W, Hoffmeister HE. Aprotinin in cardiopulmonary bypass. Effects on the Hageman factor (FXII)-kallikrein system and blood loss. Blood Coagul Fibrinolysis. 1992;3 : 99-104.
12. Katz W, Mammen EF, Thal AP. Inhibition of fibrinolysis during extracorporeal circulation. Surg Forum. 1965;16 : 63-4.
13. Royston D, Bidstrup B, van Oeveren W, Mueller W, Fritz H, Wildevuur C. Reduction in blood loss following open heart surgery: beneficial effect of high dose aprotinin. Anaesth Intensive Med. 1986;17 : 20-5.
14. Royston D. High dose aprotinin therapy: a review of the first five years experience. Cardiothorac Vasc Anaesth. 1992;76 : 76-100.
15. Wendel HP, Heller W, Michel J, et al. Lower cardiac troponin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage. J Thorac Cardiovasc Surg. 1995;109:1164-72.
16. Sunamori M, Amano J, Kameda T, Okamura T, Ozeki M, Suzuki A. Additive protection of aprotinin, a protease inhibitor to cold cardioplegia from ischemic myocardium. Jpn Circ J. 1980;44 : 71-5.
17. Hjelms E, Waldorff S, Steiness B, Bergsten O. Aprotinin does not add protective effect to cold cardioplegia during coronary artery bypass surgery. Scand J Thor Cardiovasc Surg. 1986;20 : 11-3.
18. Hütter JF, Piper HM, Spieckermann PG. An index for estimation of oxygen consumption in rat heart by hemodynamic parameters. Am J Physiol. 1985;249 : H729-4.
19. Hoffmeister HM, Storf R, Seipel L. Effects of graded intensity of oxygen deficiency on function and energy metabolism in postischaemic myocardium. Cardiovasc Res. 1988;22 : 881-8.
20. Asayama J, Yamahara Y, Ohta B, et al. Release kinetics of cardiac troponin T in coronary effluent from isolated rat hearts during hypoxia and reoxygenation. Basic Res Cardiol. 1992;87: 428-36.
21. Hoffmeister HM, Schaper J, Beyer ME, Kazmaier S, Seipel L. Effects of positive inotropic stimulation on postischemic myocardium with graded dysfunction. Cardiovasc Res. 1997;33 : 332-40.
22. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47 : 1-9.
23. Sunamori M, Innami R, Amano J, Suzuki A, Harrison CE. Role of protease inhibition in myocardial preservation in prolonged hypothermic cardioplegia followed by reperfusion. J Thorac Cardiovasc Surg. 1988;96 : 314-20.
24. Sunamori M, Sultan I, Suzuki M. Effect of aprotinin to improve myocardial viability in myocardial preservation followed by reperfusion. Ann Thorac Surg. 1991;52 : 971-8.
25. Wildevuur CR, Eijsman L, Roozendaal KJ, Harder MP, Chang M, van Oeveren W. Platelet preservation during cardiopulmonary bypass with aprotinin. Eur J Cardiothorac Surg. 1989;3 : 533-8.
26. van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CR. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1990;99 : 788-96.
27. Bolli R. Mechanism of myocardial "stunning". Circulation. 1990; 82 : 723-38.
28. Sunamori M, Suzuki M. Improved efficacy of intraaortic balloon pumping by pharmacological myocardial protection for post-operative pump failure after coronary revascularization. Jpn J Surg. 1988; 18: 61-7.
29. Gurevitch J, Barak J, Hochhauser E, Paz Y, Yakirevich V. Aprotinin improves myocardial recovery after ischemia and reperfusion. J Thorac Cardiovasc Surg. 1994; 108 : 109-18.